CancerVAX Biotech
Santa Barbara
About CancerVAX Biotech
CancerVAX Biotech is a biotechnology company that develops universal cancer treatment using the body’s immune system.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $1.0M
- Funding stage: Seed
- Last round: Seed (Oct 2023)
- Website: cancervax.com
- Phone: +1 805 356-1810
Industries & Categories
Biopharma, Biotechnology, Health Care, Wellness
Social Profiles
Canonical: https://fsome.com/organization/cancervax-biotech-78643 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.